Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Dr. Laure DeMattia, a bariatric medicine specialist in Norman, Oklahoma, feels the frustration of her patients as they struggle to lose weight. Almost all of her patients at a weight-loss clinic in the suburbs south of Oklahoma City could be helped by the new class of medications such as Ozempic and Wegovy — if they could afford them. “My patients have already done Weight Watchers, Nutrisystem. They’ve done the high protein, low carb,” she said.
Laura Davisson, director of West Virginia University’s medical weight management program, said it’s a challenge to help her patients pay for the drugs. “We really have it within our power now to potentially turn around the health of this country,” but patients being unable to meet the expense, “means we’re going to increase the health care disparities.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients Amazon Pharmacy second online pharmacy to partner with Eli Lilly’s site, and could provide faster deliveries for certain patients.
Read more »
Eli Lilly teams with Amazon to offer home delivery of its Zepbound weight-loss drugAmazon Pharmacy will now deliver prescription medications for diabetes, obesity and migraines directly to patients' doors.
Read more »
Ozempic And Wegovy Rivals: Here Are The Companies Working On Competitor Weight Loss DrugsI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
Beyond Wegovy: Could the next wave of weight-loss drugs end obesity?Wegovy and Ozempic have made headlines, but a new wave of more effective drugs like Mounjaro have the potential to end obesity altogether. How will they work and are they safe?
Read more »
More teens are using weight loss drugs like Wegovy and OzempicMarina Kopf is an associate producer with the NBC News Health and Medical Unit.
Read more »
FDA approves weight-loss drug Wegovy to reduce heart-disease risksThe FDA approved the weight-loss drug Wegovy as a treatment to reduce cardiovascular risk in adults who are overweight, the first approval of its kind.
Read more »